Equity
€351,602 ▼ 52.0%
CP PHARMA paid out €400,000 in dividends. That is 2,046% of the 2025 profit.
CP PHARMA
Lifetime
20 annual accounts with figures on one time axis, 21 filings since 2005peak €77,190 (2014)
€26,030▲ 18.8%
peak €214,507 (2023)
€19,546▲ 33.1%
peak €732,056 (2024)
€351,602▼ 52.0%
€23,778▼ 64.0%
Board1 name since 2017
1 director
Documentsfilings and deeds
19-05-202673 days before the deadline
2025financial year
Gross margin from €21,912 to €26,030Result from €14,685 to €19,546Dividend €400,000Equity from €732,056 to €351,602Debts from €65,981 to €23,778Cash from €594,936 to €170,278
Key points
from the 2025 annual accountsFilings
21 annual accounts since 2005
Two of the last ten came late. The 2019 accounts came latest: 10 days after the end of the period.
Position in the sector
93.7%
Higher solvency than 95% of companies in retail trade. Sector median 33.4% · 2,453 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 31,386 companies had the same profile as CP PHARMA has now. Each dot stands for 79 companies, two years later.
93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,386 companies, not a prediction for CP PHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Appointment: (manager)
Permanent representative: · holds 186 shares · General meeting of 20-07-2017 · Gazette deed
First establishment
Avenue des Martyrs 303, Fléron
Incorporation
published on 18-06-2004 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| CP PHARMA Fléron | €375,380 | €26,030 | 93.7% | - |
| PHARMACIE ALEN Liège | €467,751 | €26,616 | 80.1% | - |
| Apotheek Baeskens Lede | €413,989 | €30,079 | 89.9% | 0 |
| APOTHEEK DEBACKERE LEEN Aalter | €354,864 | €33,227 | 70.9% | - |
| APOTHEEK VANSCHOENWINKEL Leuven | €366,242 | €19,324 | 29.5% | - |
| JONCKHEERE Consultance Stavelot | €460,876 | €26,238 | 85.3% | - |
| APOTHEEK BOURGEOIS Zele | €282,677 | €30,698 | 39.0% | - |
These companies have the same main activity as CP PHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €283,000 and €468,000, founded between 1995 and 2006.
Official details
Source: KBO- Status
- Active since 19-05-2004Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Establishment unit
- 2.137.978.5824620 Fléron, since 16-07-2004
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Annual accounts 2025
- ≈ €120,000estimated
- €375,380▼ 53.0%
- Filing
- Filed on 19-05-2026, 73 days before the end of the filing period
Insights on CP PHARMA
CP PHARMA has been active since 2004 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €351,602 and a net result of €19,546.
Equity has been growing by about 7.9% per year since 2018. Its solvency ranks better than 95% of 2,453 sector peers (NACE 47, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about CP PHARMA
- What is the company number of CP PHARMA?
- The company number of CP PHARMA is 0865.720.644. The VAT number is the same number with BE in front: BE 0865.720.644.
- Where is CP PHARMA based?
- The registered office is at Avenue des Martyrs 303, 4620 Fléron.Company details
- What does CP PHARMA do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of CP PHARMA?
- CP PHARMA is a private limited company (pre-2019) (BVBA).
- When was CP PHARMA founded?
- CP PHARMA was founded on 19-05-2004.
- Is CP PHARMA still active?
- Yes, CP PHARMA is an active enterprise in the KBO register.
- What is the turnover of CP PHARMA?
- The turnover in financial year 2025 is ≈ €120,000. This figure is estimated from the gross margin of €26,030 and 72 comparable companies (NACE 477). It probably lies between €66,000 and €220,000.Financials
- Is CP PHARMA profitable?
- In financial year 2025, CP PHARMA made a profit of €19,546.
- Where can I find the annual accounts of CP PHARMA?
- CP PHARMA filed 21 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of CP PHARMA due?
- CP PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.